| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 20611 |
|
5,687 |
2,373 |
$142K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,053 |
1,053 |
$46K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,746 |
1,572 |
$42K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
603 |
603 |
$24K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
378 |
150 |
$4K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
76 |
27 |
$2K |
| 20610 |
|
379 |
191 |
$1K |
| 95910 |
|
12 |
12 |
$415.35 |
| 95886 |
|
12 |
12 |
$385.96 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
156 |
153 |
$153.35 |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
4,072 |
1,488 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
14 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
14 |
12 |
$0.00 |